ANAPTYSBIO, INC — Institutional Ownership
Which tracked institutions hold ANAB, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
25
Funds holding
$449399962
Total value held
Buying
19 added/new · 6 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $124473310 | 1844049 | +162669 | +9.67% |
| 2 | State Street Corp | $86818095 | 1286194 | +293749 | +29.60% |
| 3 | Sanofi | $55479398 | 821917 | +821917 | NEW BUY |
| 4 | Goldman Sachs Group Inc | $39424725 | 584070 | +251327 | +75.53% |
| 5 | Bank Of America Corp /De/ | $28202310 | 417812 | -83274 | -16.62% |
| 6 | Federated Hermes, Inc. | $26437523 | 391667 | +391667 | NEW BUY |
| 7 | Morgan Stanley | $17353682 | 257091 | -736814 | -74.13% |
| 8 | Northern Trust Corp | $13686773 | 202767 | +19248 | +10.49% |
| 9 | Invesco Ltd. | $13638781 | 202056 | +202056 | NEW BUY |
| 10 | Ubs Group Ag | $9911161 | 146832 | +146832 | NEW BUY |
| 11 | Franklin Resources Inc | $7219058 | 106949 | +41129 | +62.49% |
| 12 | Citigroup Inc | $6690195 | 99114 | +25661 | +34.94% |
| 13 | Prudential Financial Inc | $5800410 | 85932 | +21882 | +34.16% |
| 14 | Jpmorgan Chase & Co | $5293169 | 80236 | +68591 | +589.02% |
| 15 | Bank Of New York Mellon Corp | $3807069 | 56401 | +5286 | +10.34% |
| 16 | Wells Fargo & Company/Mn | $2815253 | 41707 | +8527 | +25.70% |
| 17 | Sei Investments Co | $888368 | 13161 | +5507 | +71.95% |
| 18 | Janus Henderson Group Plc | $413879 | 7464 | +7464 | NEW BUY |
| 19 | Barclays Plc | $344723 | 5107 | -2333 | -31.36% |
| 20 | Marex Group Ltd | $334935 | 4962 | +4962 | NEW BUY |
| 21 | Royal Bank Of Canada | $252000 | 3740 | -479 | -11.35% |
| 22 | Us Bancorp \De\ | $107663 | 1595 | -40 | -2.45% |
| 23 | Pnc Financial Services Group, Inc. | $7020 | 104 | -5 | -4.59% |
| 24 | Fifth Third Bancorp | $405 | 6 | +6 | NEW BUY |
| 25 | Amalgamated Financial Corp. | $57 | 2321 | +2321 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.